Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci

  1. Claude Philippe
  2. Dulce B Vargas-Landin
  3. Aurelien J Doucet
  4. Dominic van Essen
  5. Jorge Vera-Otarola
  6. Monika Kuciak
  7. Antoine Corbin
  8. Pilvi Nigumann
  9. Gaël Cristofari  Is a corresponding author
  1. Institute for Research on Cancer and Aging of Nice, France
  2. Institute for Research on Cancer and Aging of Nice, INSERM U1081, CNRS UMR 7284, University of Nice-Sophia-Antipolis, France
  3. 1Institute for Research on Cancer and Aging of Nice, France
  4. Ecole Normale Supérieure de Lyon, France

Abstract

LINE-1 (L1) retrotransposons represent approximately one sixth of the human genome, but only the human-specific L1HS-Ta subfamily acts as an endogenous mutagen in modern humans, reshaping both somatic and germline genomes. Due to their high levels of sequence identity and the existence of many polymorphic insertions absent from the reference genome, the transcriptional activation of individual genomic L1HS-Ta copies remains poorly understood. Here we comprehensively mapped fixed and polymorphic L1HS-Ta copies in 12 commonly-used somatic cell lines, and identified transcriptional and epigenetic signatures allowing the unambiguous identification of active L1HS-Ta copies in their genomic context. Strikingly, only a very restricted subset of L1HS-Ta loci - some being polymorphic among individuals - significantly contributes to the bulk of L1 expression, and these loci are differentially regulated among distinct cell lines. Thus, our data support a local model of L1 transcriptional activation in somatic cells, governed by individual-, locus-, and cell-type-specific determinants.

Article and author information

Author details

  1. Claude Philippe

    INSERM U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging of Nice, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Dulce B Vargas-Landin

    INSERM U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging of Nice, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Aurelien J Doucet

    Faculty of Medicine, Institute for Research on Cancer and Aging of Nice, INSERM U1081, CNRS UMR 7284, University of Nice-Sophia-Antipolis, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Dominic van Essen

    INSERM U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging of Nice, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Jorge Vera-Otarola

    INSERM U1081, CNRS UMR 7284, 1Institute for Research on Cancer and Aging of Nice, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Monika Kuciak

    Faculty of Medicine, Institute for Research on Cancer and Aging of Nice, INSERM U1081, CNRS UMR 7284, University of Nice-Sophia-Antipolis, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Antoine Corbin

    Ecole Normale Supérieure de Lyon, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Pilvi Nigumann

    INSERM U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging of Nice, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Gaël Cristofari

    INSERM U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging of Nice, Nice, France
    For correspondence
    Gael.Cristofari@unice.fr
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Kathy Burns, McKusick-Nathans Institute of Genetic Medicine, United States

Version history

  1. Received: December 18, 2015
  2. Accepted: March 25, 2016
  3. Accepted Manuscript published: March 26, 2016 (version 1)
  4. Version of Record published: May 13, 2016 (version 2)

Copyright

© 2016, Philippe et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,324
    Page views
  • 1,223
    Downloads
  • 114
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Claude Philippe
  2. Dulce B Vargas-Landin
  3. Aurelien J Doucet
  4. Dominic van Essen
  5. Jorge Vera-Otarola
  6. Monika Kuciak
  7. Antoine Corbin
  8. Pilvi Nigumann
  9. Gaël Cristofari
(2016)
Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci
eLife 5:e13926.
https://doi.org/10.7554/eLife.13926

Share this article

https://doi.org/10.7554/eLife.13926

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Maria L Adelus, Jiacheng Ding ... Casey E Romanoski
    Research Article

    Heterogeneity in endothelial cell (EC) sub-phenotypes is becoming increasingly appreciated in atherosclerosis progression. Still, studies quantifying EC heterogeneity across whole transcriptomes and epigenomes in both in vitro and in vivo models are lacking. Multiomic profiling concurrently measuring transcriptomes and accessible chromatin in the same single cells was performed on six distinct primary cultures of human aortic ECs (HAECs) exposed to activating environments characteristic of the atherosclerotic microenvironment in vitro. Meta-analysis of single-cell transcriptomes across 17 human ex vivo arterial specimens was performed and two computational approaches quantitatively evaluated the similarity in molecular profiles between heterogeneous in vitro and ex vivo cell profiles. HAEC cultures were reproducibly populated by four major clusters with distinct pathway enrichment profiles and modest heterogeneous responses: EC1-angiogenic, EC2-proliferative, EC3-activated/mesenchymal-like, and EC4-mesenchymal. Quantitative comparisons between in vitro and ex vivo transcriptomes confirmed EC1 and EC2 as most canonically EC-like, and EC4 as most mesenchymal with minimal effects elicited by siERG and IL1B. Lastly, accessible chromatin regions unique to EC2 and EC4 were most enriched for coronary artery disease (CAD)-associated single-nucleotide polymorphisms from Genome Wide Association Studies (GWAS), suggesting that these cell phenotypes harbor CAD-modulating mechanisms. Primary EC cultures contain markedly heterogeneous cell subtypes defined by their molecular profiles. Surprisingly, the perturbations used here only modestly shifted cells between subpopulations, suggesting relatively stable molecular phenotypes in culture. Identifying consistently heterogeneous EC subpopulations between in vitro and ex vivo models should pave the way for improving in vitro systems while enabling the mechanisms governing heterogeneous cell state decisions.

    1. Chromosomes and Gene Expression
    Fujun Zhou, Julie M Bocetti ... Jon R Lorsch
    Research Article

    We have developed a deep sequencing-based approach, Rec-Seq, that allows simultaneous monitoring of ribosomal 48S preinitiation complex (PIC) formation on every mRNA in the translatome in an in vitro reconstituted system. Rec-Seq isolates key early steps in translation initiation in the absence of all other cellular components and processes. Using this approach, we show that the DEAD-box ATPase Ded1 promotes 48S PIC formation on the start codons of >1000 native mRNAs, most of which have long, structured 5′-untranslated regions (5′UTRs). Remarkably, initiation measured in Rec-Seq was enhanced by Ded1 for most mRNAs previously shown to be highly Ded1-dependent by ribosome profiling of ded1 mutants in vivo, demonstrating that the core translation functions of the factor are recapitulated in the purified system. Our data do not support a model in which Ded1acts by reducing initiation at alternative start codons in 5′UTRs and instead indicate it functions by directly promoting mRNA recruitment to the 43S PIC and scanning to locate the main start codon. We also provide evidence that eIF4A, another essential DEAD-box initiation factor, is required for efficient PIC assembly on almost all mRNAs, regardless of their structural complexity, in contrast to the preferential stimulation by Ded1 of initiation on mRNAs with long, structured 5′UTRs.